Symbol="BIO"
AssetType="Common Stock"
Name="Bio-Rad Laboratories Inc"
Description="Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets."
CIK="12208"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="1000 ALFRED NOBEL DRIVE, HERCULES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11612930000"
EBITDA="555521000"
PERatio="31.53"
PEGRatio="1.074"
BookValue="329.76"
DividendPerShare="0"
DividendYield="0"
EPS="-6.25"
RevenuePerShareTTM="93.57"
ProfitMargin="-0.0688"
OperatingMarginTTM="0.15"
ReturnOnAssetsTTM="0.0186"
ReturnOnEquityTTM="-1.895"
RevenueTTM="2779031000"
GrossProfitTTM="1568430000"
DilutedEPSTTM="-6.94"
QuarterlyEarningsGrowthYOY="1.978"
QuarterlyRevenueGrowthYOY="-0.033"
AnalystTargetPrice="551"
TrailingPE="-"
ForwardPE="28.01"
PriceToSalesRatioTTM="4.418"
PriceToBookRatio="1.517"
EVToRevenue="4.358"
EVToEBITDA="-1.591"
Beta="0.886"
num_52WeekHigh="572.7"
num_52WeekLow="344.63"
num_50DayMovingAverage="379.65"
num_200DayMovingAverage="424.27"
SharesOutstanding="23984600"
DividendDate="None"
ExDividendDate="None"
symbol="BIO"
open="398.88"
high="398.88"
low="391.57"
price="396.57"
volume="171925.00"
latest_trading_day="2023-07-14"
previous_close="397.78"
change="-1.21"
change_percent="-0.3042%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="57"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="199130"
Change_recent_avg="0.08"
Delta_recent_avg="11.27"
Variance_recent_avg="5.64"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="1115"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0148.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="1016"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0178.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
